Evidence map›Paper›PMID 39234595›Full record

ArticleBiochemistry and biophysics reports2024

Eggshell membrane and its major component lysozyme and ovotransferrin enhance the secretion of decorin as an endogenous antifibrotic mediator from lung fibroblasts and ameliorate bleomycin-induced pulmonary fibrosis.

Eri Ohto-Fujita, Miho Shimizu, Aya Atomi, Hiroki Hiruta, Ryota Hosoda, Shinya Horinouchi, Shinya Miyazaki, Tomoaki Murakami, Yoshihide Asano, Yukio Hasebe and 1 more

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Pharmacokinetic Profiling UsingInternational journal of molecular sciences · 2025
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eri Ohto-FujitaMaterial Health Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology (TUAT), Tokyo, 184-8588, Japan.
Miho ShimizuMaterial Health Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology (TUAT), Tokyo, 184-8588, Japan.
Aya AtomiMaterial Health Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology (TUAT), Tokyo, 184-8588, Japan.
Hiroki HirutaMaterial Health Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology (TUAT), Tokyo, 184-8588, Japan.
Ryota HosodaMaterial Health Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology (TUAT), Tokyo, 184-8588, Japan.
Shinya HorinouchiMaterial Health Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology (TUAT), Tokyo, 184-8588, Japan.
Shinya MiyazakiCooperative Dep. Veterinary Medicine, Tokyo University of Agriculture and Technology, Tokyo, 183-8509, Japan.
Tomoaki MurakamiCooperative Dep. Veterinary Medicine, Tokyo University of Agriculture and Technology, Tokyo, 183-8509, Japan.
Yoshihide AsanoDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Yukio HasebeAlmado, Inc., Tokyo, 104-0031, Japan.
Yoriko AtomiMaterial Health Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology (TUAT), Tokyo, 184-8588, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is a high-risk factor for obstructive and fibrotic lung diseases. Fibrotic lung disease leading to decreased lung function is characterized by interstitial remodeling and tissue scarring (sclerosis), with destruction of alveoli and excess deposition of type I collagen, an extracellular matrix component secreted by fibroblasts. Therefore, regulating transforming growth factor-β (TGF-β) as a profibrotic signal is essential to suppress pulmonary fibrosis. In pulmonary fibrosis, TGF-β signaling is mediated by Smad and YAP/TAZ, and TAZ linked to the pathology of pulmonary function is observed in lung fibroblasts from patients with idiopathic pulmonary fibrosis. Although fibrosis is thought to be irreversible, it is an interventional condition. Decorin (DCN) blocks TGF-β signaling in pulmonary fibrosis, although there are no cellular pharmacological methods to stimulate DCN secretion. We previously showed that chicken eggshell membrane (ESM, a well-known wound-healing material) promotes

Indexed as

DecorinEggshell membraneLysozymeOvotransferrinPulmonary fibrosis

Identifiers

PMID39234595
PMCPMC11372621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.